A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522

Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori

Transcriptome analysis of plasmid-induced genes sheds light on the role of type I IFN as adjuvant in DNA vaccine against infectious salmon anemia virus

Parenteral adjuvant potential of recombinant B subunit of Escherichia coli heat-labile enterotoxin

Enhanced Immune Response to Rabies Viruses by the Use of a Liposome Adjuvant in Vaccines

Immune Effect of Newcastle Disease Virus DNA Vaccine with C3d as a Molecular Adjuvant

Gene expression of bovine embryos developing at the air-liquid interface on oviductal epithelial cells (ALI-BOEC)

Engineering intranasal mRNA vaccines to enhance lymph node trafficking and immune responses

Recombinant hemagglutinin proteins formulated in a novel PELC/CpG adjuvant for H7N9 subunit vaccine development

Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration